Category: Autoimmune
Global Autoimmune
-
The 2025-2030 World Outlook for Monocyte Activation Test Kits
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Lupus Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Cell Therapy Market Report by Cell Type (Stem Cell, Non-stem Cell), Therapy Type (Autologous, Allogeneic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032
... Region 2024-2032 The global cell therapy market size reached US$ 13.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 15.28% ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2024-2032
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2024-2032 The global biosimilar market size reached US$ 21.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 164.5 Billion by 2032, exhibiting ... Read More
-
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
... has released a research report titled “Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)” which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market ... Read More
-
Global Interleukin Industry Research Report Growth Trends and Competitive Analysis 2024-2030
... with a CAGR of 9.88% during the forecast period 2024-2030. The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with ... Read More
-
Global Systemic Lupus Erythematous SLE Drug Market Growth 2024-2030
... growing demand in downstream market, the Systemic Lupus Erythematous SLE Drug is forecast to a readjusted size of US$ 265.8 million by 2030 with a CAGR of 4.9% during review period. The research report highlights ... Read More
-
Small Molecule Active Pharmaceutical Ingredient Global Market Report 2024
... 3) By Manufacturing Method: In-House; Contract 4) By Application: Clinical; CommercialCovering: Pfizer Inc.; BASF SE; Roche Holding AG; F. Hoffmann-La Roche Limited; AbbVie Inc. Small Molecule Active Pharmaceutical Ingredient Global Market Report 2024 from The ... Read More
-
Lupus Nephritis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Injectable Drug Delivery Devices Global Market Report 2024
... Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories Covering: Becton, Dickinson and Company; Baxter International; Gerresheimer AG; B. Braun Melsungen AG; Catalent, Inc. Injectable Drug Delivery Devices Global Market Report 2024 from The ... Read More
-
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029. Segmented By Technology (Sequencing by Synthesis, Sequencing by Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-use (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage) Region and Competition
... (SMRT) Sequencing), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-use (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage) Region and Competition Global ... Read More
-
Global In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Global In-vitro diagnostics market is projected to ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... according to Renub Research. Autoimmune diseases are diverse situations wherein the immune system mistakenly attacks the body's cells, tissues, and organs. These outcomes result in irritation and harm, causing various symptoms. Over 80 diagnosed autoimmune ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032
... erythematosus (SLE) drugs market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.83% during 2024-2032.The increasing ... Read More
-
Global Lupus Nephritis Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Lupus Nephritis industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Lupus Nephritis. The report also introduces players in the industry ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
IVD & LDT For Autoimmune Diseases Market by Technology (Clinical Chemistry, Coagulation, Hematology), Application (Addison’s Disease, Alopecia Areata, Ankylosing Spondylitis) - Global Forecast 2024-2030
... at USD 17.27 billion in 2023 and expected to reach USD 18.30 billion in 2024, at a CAGR 5.22% to reach USD 24.68 billion by 2030. Global IVD & LDT For Autoimmune Diseases Market FPNV ... Read More
-
Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2024-2030
... estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
Research Assistance
